MKP1 regulates the induction of inflammatory response by pneumococcal pneumolysin in human epithelial cells

Hee-Sung Shin1, In-Hwa Yoo, Yong-Jae Kim

  • 1Department of Biotechnology and Bioinformatics, Korea University, Chungnam, Korea.

Insights

Pneumolysin, a bacterial toxin, reduces the expression of tumor necrosis factor-alpha (TNF-α) by increasing MAPK phosphatase 1 (MKP1) early in infection. This study clarifies how pneumolysin impacts innate immune responses.

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Proinflammatory cytokines are crucial for innate immune responses during infection.
  • Reduced cytokine expression can impair host defenses.
  • Pneumolysin's reduced inflammatory effect in early treatment stages requires explanation.

Purpose of the Study:

  • To elucidate the mechanism by which pneumolysin affects proinflammatory cytokine expression.
  • To investigate the role of MAPK phosphatase 1 (MKP1) in pneumolysin-induced immune modulation.

Main Methods:

  • Assessing tumor necrosis factor-alpha (TNF-α) expression in human epithelial cells.
  • Measuring the expression of MAPK phosphatase 1 (MKP1) in response to pneumolysin.
  • Analyzing the time-dependent regulation of TNF-α by p38 mitogen-activated protein kinase (MAPK) and MKP1.

Main Results:

  • Pneumolysin significantly increased MKP1 expression early in treatment.
  • MKP1 was found to reduce TNF-α expression.
  • TNF-α expression was regulated in a time-dependent manner by p38 MAPK, which is controlled by MKP1.

Conclusions:

  • Pneumolysin upregulates MKP1 expression, which subsequently suppresses TNF-α production.
  • This mechanism reveals a novel role for pneumolysin in the time-dependent regulation of innate immune responses.
  • Understanding this interaction is key to comprehending host defense modulation during bacterial infections.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...